NPPA suggests expanding the list of essential medicines whose prices are controlled
Industry fears tougher US stance on IP after President Donald Trump asserted that foreign countries must pay a fair share for drug development costs. Aneesh Phadnis reports.
Jaitley said he is meeting the existing investors and potential investors, those who are looking at India, those who are looking to expand.
A certain segment of the US pharma industry have become vocal about Indian policies on domestic content requirements and IPR.
Kamil's elder sister Samina Vaziralli has taken on an expanded role
At least two key drugs in the gliptin category have already gone off patent and cheaper variants are crowding the market. Also, several patent expiries are round the corner for the newest category of drugs - SGLT-2 inhibitors or gliflozins.
Western drugmakers, including Pfizer Inc, Novartis AG, Roche Holding AG and Sanofi SA, covet a bigger share of the fast-growing Indian drugs market.
Lobby group tells USTR it has got assurance from India on compulsory licensing.
Increased price control over branded generic medicines has affected its profitability
Irrespective of demonetisation and GST blues, IIM Lucknow has been able to successfully place their batch of 459 students.
Nearly 150 companies visited the campus this year.
Those scheduled to attend the five-day WEF Annual meeting, beginning January 21, include more than 40 heads of state or government, including those from the UK, Australia, Japan, Iran, Israel, Pakistan, Brazil, Italy, Mauritius, Republic of Korea and Switzerland, WEF announced on Wednesday at a press conference in Geneva.
Launches cloud-based version of solution to target mid-size clients in life sciences.
The proposed acquisition is expected to close by the end of 2014, subject to approvals from Indian Courts and the anti-trust body in India and the US
FDA inspectors visited the Mohali plant in the process of giving approval to Ranbaxy's application for Valsartan.
Financials were the top losers while oil shares also declined amid weak crude oil prices.
Wealth of the richest 62 people has risen 44% in the five years since 2010, while that of the bottom half fell by 41%
A football fan, Kamil Hamied is known to be a calm and quiet person who wants to do something for society, like his uncle Yusuf.
The annual talk-fest of rich and powerful from across the world in snow-laden Alpine resort town of Davos will be attended by nearly 40 heads of government among more than 2,500 global leaders from over 100 countries.
Flaring of tempers comes atop much simmering trouble on clashing views; these stands might now get frozen.
Pakistani Prime Minister Nawaz Sharif has cancelled his visit to WEF annual meeting after a deadly Taliban attack in his country.
BSE Midcap and Smallcap indices ended in line with their larger counterparts and closed marginally up 0.2% and 0.4%, each
Pharma major Lupin and mortgage lender HDFC were the top losers.
Sensex closed the day 416 points higher.
Engineering major BHEL rebounded from its day's lows to end around 1% higher.
It's time for Indian generic companies to rethink their strategies.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances